Julie Bloom

Radiation Oncologist @MountSinaiNYC | #WomensHealth | #ClimateHealth | Bee-enthusiast

[ASTRO @ASTRO_org]

ASTRO announces 2026 election results:

Congratulations to our newly elected members of ASTRO’s Board of Directors and Nominating Committee members. Terms officially begin on September 29, 2026, at the ASTRO Annual Meeting.

Read the news release: https://t.co/2MtTLT8Dnf

@BethEri81895034 @ken4englewood @DrJohnSuh @carmenbergom

[Julie Bloom @JulBloom]

As there is an increased use of AI in clinic, real-time prediction based on clinical metrics we already gather (symptoms and vitals) may allow for early identification of high-risk patients and personalized toxicity management/screening.

[Julie Bloom @JulBloom]

Utilizing natural language processing, modeling which incorporated real-time clinical on-treatment variables predicted development of radiation pneumonitis post chemoRT in advanced lung cancer. @eClinicalMed @TischCancer @QuadShotNews
https://t.co/74bd6MFRET

[Speed of Light - The ASTRO Foundation @SpeedofLightFdn]

Congratulations to the winners of the 2026 Publication Excellence Awards!

Join Speed of Light – The ASTRO Foundation in recognizing these emerging leaders in radiation oncology during the Research Honors presentation at 9:00 a.m. on Mon., Sep. 28, before the keynote address at #ASTRO26 in Boston.

Learn more about the winners: https://t.co/0gCgEFSW6J

@karamarieruicci @ZihangChenMD @Jalal_Ahmed

[PDBrown @PDBrownOnc]

Less Isn't Simple: Insights From Postmastectomy Radiotherapy Deintensification Trials | Journal of Clinical Oncology https://t.co/aEicbaAakw

[Julie Bloom @JulBloom]

Excited to officially welcome these fantastic doctors to the Mount Sinai RO family

[Mount Sinai Radiation Oncology Residents @MSROResidents]

We are thrilled to announce our 2026 match results. Shivatej Dubbaka, Orli Weiss, and Catherine Yu will join us July 1, 2027

[Julie Bloom @JulBloom]

Could not think of a better physician to be the voice of radiation oncology within ASCO. @KarynAGoodman

[Karyn Goodman, MD, MS @KarynAGoodman]

Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the Designated Radiation Oncologist seat on the Board of Directors. Visit https://t.co/XPxOFR0twa to learn more about the candidates and place your vote!

[Mount Sinai Tisch Cancer Center @TischCancer]

In Biomedicines: Role of immunotherapy and radiation therapy in early-stage, locally advanced, recurrent, metastatic #BreastCancer.
https://t.co/Zer7GVKY2M
@MountSinaiRO @RimapatelMD @rsamstein Amy Tiersten, MD @IcahnMountSinai
#BreastCancerAwarenessMonth @MDPIOpenAccess

[Icro Meattini @Icro_Meattini]

Juliane Horner-Rieber presented a timely systematic review & meta-analysis comparing moderate hypofractionation vs 2 Gy/fx for RNI & PMRT #ASTRO25

🟰 Oncological outcomes
🔒 Comparable safety
✅ Moderate hypo standard of care

#radonc #breastcancer #OncoAlert @OncoAlert

[Mount Sinai Radiation Oncology Residents @MSROResidents]

A reminder to *Radiation Oncology applicants*

Our first meet and greet is tomorrow - we are excited to meet you!

[Mount Sinai Radiation Oncology Residents @MSROResidents]

*Radiation Oncology applicants*

Please join us for a virtual meet and greet:

*Tuesday, August 26 at 7 pm EST*

*Thursday, September 18 at 7 pm EST*

Please sign up below!

@ARRO_org @Inside_TheMatch

[Huck constance @ConstanceHuck]

New insights on SBRT in recurrent ovarian cancer – now in CTRO:
“SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic review”
👉 https://t.co/AbnJgiAnoH

🎯 Local control
⏳ Delayed systemic therapy
⚖️ Personalized strategy
@EORTC

[Stanislav (Stas) Lazarev, MD @StasLazarev]

⚡️⚡️NEW STUDY - presented today at #ARS2025 in an oral talk by MS2 Yarelis Roque-Reyes from UCC School of Medicine, PR

🧠💥 Does whole brain RT (WBRT) help patients hospitalized with symptomatic leptomeningeal disease (LMD)?

Our @MountSinaiRO study suggests: rarely — and in reality, it may be more harmful to patients’ quality of life and end-of-life care.
🧵👇 #radonc #neuroonc #endoflifecare #ARS2025

LMD is a devastating CNS complication with 3–6 mo survival. WBRT is often used for palliation — but for patients sick enough to need hospital admission, we asked:

👉 Does it actually help?

We reviewed 58 such patients (2014–2023). Here’s what we found ⬇️

📊 Symptom response after WBRT:
❌ 74% worsened
➖ 21% no change
✅ Only 5% improved

💀 Short-term mortality:
40% at 30 days
60% at 60 days
76% at 90 days

📉 ECOG declined in 79%

⏳ 30% spent >⅓ of their remaining lifespan on treatment — often in the hospital

🎯 Our takeaways
➡️ In hospitalized patients with symptomatic LMD, WBRT provides little to no clinical benefit

➡️ with few exceptions, best supportive care — not burdensome WBRT — should be the priority

➡️time to rethink WBRT in hospitalized pts with LMD?

👏 Congrats to Yarelis Roque-Reyes on her #ARS2025 oral talk!
@sindhu_kunal @MountSinaiRO @QuadShotNews

[Mount Sinai Radiation Oncology Residents @MSROResidents]

One of our chief residents @DanielDickstein presented his work on navigating treatment discussions with patients from sexual and gender minority populations with prostate cancer at #ASTRO2024

[Julie Bloom @JulBloom]

It is always especially exciting to see your mentor up on the big stage. Thank you @rsamstein for sharing your wisdom!

[Mount Sinai Radiation Oncology @MountSinaiRO]

@rsamstein discussing the results of NRG Lu-005 at the Plenary Session at #ASTRO2024 @ASTRO_org

[Julie Bloom @JulBloom]

What a crew!

[Mount Sinai Radiation Oncology Residents @MSROResidents]

@MSROResidents are at #ASTRO2024 @ASTRO_org @DanielDickstein @JulianaRunnels

[Shankar Siva @_ShankarSiva]

📣@DavidKrugMD presents the primary outcome of HYPO-SIB trial in #breastcancer. Safe, effective and non-inferior to long course RT. Concordant with IMPORT and RTOG trial of 3-week #radiotherapy+integrated boost #bcsm. Great discussion by @KimCorbinMD 👏🏽👏🏽 #ASTRO24 #radonc

[Pierre Blanchard, MD @PBlanchardMD]

Major congrats to my friend Dr Sofia Rivera on the HypoG-01 just presented at #ESMO2024

Hypofractionation not inferior to conventional fractionation for #BreastCancer with nodal RT.

✅Similar toxicity
✅Similar efficacy (BCSM OS LRFS DMFS)

3 weeks is the way to go!

[Mount Sinai Radiation Oncology @MountSinaiRO]

🌟 Join us for the Women in Radiation Oncology Virtual Event! 🌟

Connect with and learn from leading experts in the field. Don’t miss this opportunity to advance your career and network with peers. Register now!

#WomenInRadiationOncology  #RadiationOncology #WomenInSTEM

[Mount Sinai Radiation Oncology Residents @MSROResidents]

🌟 Join us for the Women in Radiation Oncology Virtual Event! 🌟

Connect with and learn from leading experts in the field. Don’t miss this opportunity to advance your career and network with peers. Register now!

#WomenInRadiationOncology  #RadiationOncology #WomenInSTEM